Rising Pharma Holding, Inc. 2026-03-11 Health serious FDA
Health · FDA · Recall #FDA-D-0384-2026
Product label: Temozolomide Capsules, 5mg, packaged in 5-capsule bottles, Rx only,… Recall
Issued March 11, 2026 · Rising Pharma Holding, Inc.
In March 2026, Rising Pharma Holding, Inc. recalled the Product label: Temozolomide Capsules, 5mg, packaged in 5-capsule bottles, Rx only,…, a serious health recall reported by the FDA.
Compiled by Maya Ellison, RecallCheckr
What this means for you
Failed Impurities/Degradation Specifications: An out-of-specification result observed during 9th-month long term stability testing
What you should do
- 1 Stop using Product label: Temozolomide Capsules, 5mg, packaged in 5-capsule bottles, Rx only,… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact Rising Pharma Holding, Inc. to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- Rising Pharma Holding, Inc.
- Category
- Health
- Recall date
- March 11, 2026
- Units affected
- Not reported
- Sold at
- Nationwide within the U.S
- Recall number
- FDA-D-0384-2026
- Made in
- United States
- Issuing agency
- FDA
In context
- Rising Pharma Holding, Inc. has 3 recalls in our database.
- We're tracking 3,576 Health recalls in our database.
- This is the 356th Health recall we've logged in 2026.